One learner who embodies this spirit is Prince Morapedi, a 2025 matriculant and RCL member. For him, leadership is rooted in ...
Gilead Sciences has bolstered its position in the development of next-generation cancer cell therapies with a deal to absorb Tmunity Therapeutics into its Kite unit. Kite has agreed to acquire all the ...